Navigation Links
Novel MRI Technique Shows Secondhand Smoke Damages Lungs
Date:11/26/2007

Monday, Nov. 26.

RSNA is an association of more than 41,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. The Society is based in Oak Brook, Ill. (RSNA.org)

Editor's note: The data in these releases may differ from those in the printed abstract and those actually presented at the meeting, as researchers continue to update their data right up until the meeting. To ensure you are using the most up-to-date information, please call the RSNA Newsroom at 1-312-949-3233.


'/>"/>
SOURCE Radiological Society of North America
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel Cooling Therapy May Have Aided Injured Football Player
3. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
4. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...rding the treatment of AIDS/HIV infection that has...f a global research, AIDS still remains a puzzle t...nt of patients with HIV, or human immunodeficiency...very slowly.// Past research suggested that such ...
...s who make fewer visits to the dentists than their... the fact that smoking puts them more at risk from...holds true regardless of age, gender, race, ethnic..., location and insurance coverage. The study, repo...
...sity College of Medicine and Public Health had fou...esponding well to other treatments might be treate...NS) with significantly better results.// As an al...pproved the implantation of a vagus nerve stimulat...
...ch the oxygen-carrying protein in the red blood ce...ickled) shape that can disrupt circulation, leadin...es fatal complications. // "Sickle cell anemia is...disables children as they grow," according to Dr.W...
Other Medicine News:Health News:Study holds promise for new way to fight HIV 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:7/22/2008)...alidated by Columbia University Medical Center Bas...oRNA Technology, The Test Differentiates Squamou...SCLC), Classifying Squamous-Cell Carcinoma of the ...cificity of 90 Percent,This is the First CLIA Appr... as Biomarkers for Accurate Diagnosis of Lu...
(Date:7/22/2008)...ests That Ekkyo,s New Approach of LASH (Laser Assi...r Healing Physiology, MARSEILLES, France, July 22... Technology) a photomedicine company, which develo...r prevention and reduction, announced today,the pu...gery and Medicine*,reporting the results of a pilo...
(Date:7/21/2008).../- The SEAS (Simvastatin and Ezetimib...ffects of intensive,cholesterol lowering with the ...mibe (10 mg daily) in patients with aortic stenosi...age of the aortic valve in,the heart) is a relativ...opulations. Left untreated, it can progress to dea...
(Date:7/21/2008)...profile helps clinicians identify risk in patients...evels and statin therapy, BIRMINGHAM, Ala., July ...from Atherotech, researchers have identified a lin...n. The information could help,physicians trying to...,disease risk-lowering treatments in at-risk patie...
Breaking Medicine Technology:First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 1Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 1Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 3Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 1Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 3Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 5Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 6Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 7Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 8Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 1Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 2